PEN or VIAL

pen vial

Dosage

20mg 60mg

Decrease quantity Increase quantity

Add to cart

 

 

Tirzepatide 20mg/60mg

Tirzepatide is a synthetic peptide designed to interact with the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor pathways. It is widely studied in scientific research investigating metabolic signalling and the physiological pathways associated with these two incretin receptors.

This product is supplied in 20mg/60mg research preparations and is intended strictly for research purposes only, not for human or veterinary use. The material is independently tested by a third-party laboratory and has a reported purity of >99%.